Medical device companies are shifting their CEO compensation practices away from equity awards to performance measures based more on returns to shareholders, according to a Morgan Stanley report.
Image © 2014 Morgan Stanley. Click image to enlarge.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sqCb1u
Cap comentari:
Publica un comentari a l'entrada